Global Guselkumab Injection Market Growth 2023-2029

January 2023 | 73 pages | ID: GD620A167F2EEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Guselkumab Injection Industry Forecast” looks at past sales and reviews total world Guselkumab Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Guselkumab Injection sales for 2023 through 2029. With Guselkumab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Guselkumab Injection industry.

This Insight Report provides a comprehensive analysis of the global Guselkumab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Guselkumab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Guselkumab Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Guselkumab Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Guselkumab Injection.

The global Guselkumab Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Guselkumab Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Guselkumab Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Guselkumab Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Guselkumab Injection players cover Janssen Biotech. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Guselkumab Injection market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• 100mg Type
• Other

Segmentation by application

• Plaque Psoriasis
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Janssen Biotech

Key Questions Addressed in this Report

What is the 10-year outlook for the global Guselkumab Injection market?

What factors are driving Guselkumab Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Guselkumab Injection market opportunities vary by end market size?

How does Guselkumab Injection break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Guselkumab Injection Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Guselkumab Injection by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Guselkumab Injection by Country/Region, 2018, 2022 & 2029
2.2 Guselkumab Injection Segment by Type
  2.2.1 100mg Type
  2.2.2 Other
2.3 Guselkumab Injection Sales by Type
  2.3.1 Global Guselkumab Injection Sales Market Share by Type (2018-2023)
  2.3.2 Global Guselkumab Injection Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Guselkumab Injection Sale Price by Type (2018-2023)
2.4 Guselkumab Injection Segment by Application
  2.4.1 Plaque Psoriasis
  2.4.2 Other
2.5 Guselkumab Injection Sales by Application
  2.5.1 Global Guselkumab Injection Sale Market Share by Application (2018-2023)
  2.5.2 Global Guselkumab Injection Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Guselkumab Injection Sale Price by Application (2018-2023)

3 GLOBAL GUSELKUMAB INJECTION BY COMPANY

3.1 Global Guselkumab Injection Breakdown Data by Company
  3.1.1 Global Guselkumab Injection Annual Sales by Company (2018-2023)
  3.1.2 Global Guselkumab Injection Sales Market Share by Company (2018-2023)
3.2 Global Guselkumab Injection Annual Revenue by Company (2018-2023)
  3.2.1 Global Guselkumab Injection Revenue by Company (2018-2023)
  3.2.2 Global Guselkumab Injection Revenue Market Share by Company (2018-2023)
3.3 Global Guselkumab Injection Sale Price by Company
3.4 Key Manufacturers Guselkumab Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Guselkumab Injection Product Location Distribution
  3.4.2 Players Guselkumab Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR GUSELKUMAB INJECTION BY GEOGRAPHIC REGION

4.1 World Historic Guselkumab Injection Market Size by Geographic Region (2018-2023)
  4.1.1 Global Guselkumab Injection Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Guselkumab Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Guselkumab Injection Market Size by Country/Region (2018-2023)
  4.2.1 Global Guselkumab Injection Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Guselkumab Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Guselkumab Injection Sales Growth
4.4 APAC Guselkumab Injection Sales Growth
4.5 Europe Guselkumab Injection Sales Growth
4.6 Middle East & Africa Guselkumab Injection Sales Growth

5 AMERICAS

5.1 Americas Guselkumab Injection Sales by Country
  5.1.1 Americas Guselkumab Injection Sales by Country (2018-2023)
  5.1.2 Americas Guselkumab Injection Revenue by Country (2018-2023)
5.2 Americas Guselkumab Injection Sales by Type
5.3 Americas Guselkumab Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Guselkumab Injection Sales by Region
  6.1.1 APAC Guselkumab Injection Sales by Region (2018-2023)
  6.1.2 APAC Guselkumab Injection Revenue by Region (2018-2023)
6.2 APAC Guselkumab Injection Sales by Type
6.3 APAC Guselkumab Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Guselkumab Injection by Country
  7.1.1 Europe Guselkumab Injection Sales by Country (2018-2023)
  7.1.2 Europe Guselkumab Injection Revenue by Country (2018-2023)
7.2 Europe Guselkumab Injection Sales by Type
7.3 Europe Guselkumab Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Guselkumab Injection by Country
  8.1.1 Middle East & Africa Guselkumab Injection Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Guselkumab Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Guselkumab Injection Sales by Type
8.3 Middle East & Africa Guselkumab Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Guselkumab Injection
10.3 Manufacturing Process Analysis of Guselkumab Injection
10.4 Industry Chain Structure of Guselkumab Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Guselkumab Injection Distributors
11.3 Guselkumab Injection Customer

12 WORLD FORECAST REVIEW FOR GUSELKUMAB INJECTION BY GEOGRAPHIC REGION

12.1 Global Guselkumab Injection Market Size Forecast by Region
  12.1.1 Global Guselkumab Injection Forecast by Region (2024-2029)
  12.1.2 Global Guselkumab Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Guselkumab Injection Forecast by Type
12.7 Global Guselkumab Injection Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Janssen Biotech
  13.1.1 Janssen Biotech Company Information
  13.1.2 Janssen Biotech Guselkumab Injection Product Portfolios and Specifications
  13.1.3 Janssen Biotech Guselkumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Janssen Biotech Main Business Overview
  13.1.5 Janssen Biotech Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Guselkumab Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Guselkumab Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 100mg Type
Table 4. Major Players of Other
Table 5. Global Guselkumab Injection Sales by Type (2018-2023) & (K Units)
Table 6. Global Guselkumab Injection Sales Market Share by Type (2018-2023)
Table 7. Global Guselkumab Injection Revenue by Type (2018-2023) & ($ million)
Table 8. Global Guselkumab Injection Revenue Market Share by Type (2018-2023)
Table 9. Global Guselkumab Injection Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Guselkumab Injection Sales by Application (2018-2023) & (K Units)
Table 11. Global Guselkumab Injection Sales Market Share by Application (2018-2023)
Table 12. Global Guselkumab Injection Revenue by Application (2018-2023)
Table 13. Global Guselkumab Injection Revenue Market Share by Application (2018-2023)
Table 14. Global Guselkumab Injection Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Guselkumab Injection Sales by Company (2018-2023) & (K Units)
Table 16. Global Guselkumab Injection Sales Market Share by Company (2018-2023)
Table 17. Global Guselkumab Injection Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Guselkumab Injection Revenue Market Share by Company (2018-2023)
Table 19. Global Guselkumab Injection Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Guselkumab Injection Producing Area Distribution and Sales Area
Table 21. Players Guselkumab Injection Products Offered
Table 22. Guselkumab Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Guselkumab Injection Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Guselkumab Injection Sales Market Share Geographic Region (2018-2023)
Table 27. Global Guselkumab Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Guselkumab Injection Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Guselkumab Injection Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Guselkumab Injection Sales Market Share by Country/Region (2018-2023)
Table 31. Global Guselkumab Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Guselkumab Injection Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Guselkumab Injection Sales by Country (2018-2023) & (K Units)
Table 34. Americas Guselkumab Injection Sales Market Share by Country (2018-2023)
Table 35. Americas Guselkumab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Guselkumab Injection Revenue Market Share by Country (2018-2023)
Table 37. Americas Guselkumab Injection Sales by Type (2018-2023) & (K Units)
Table 38. Americas Guselkumab Injection Sales by Application (2018-2023) & (K Units)
Table 39. APAC Guselkumab Injection Sales by Region (2018-2023) & (K Units)
Table 40. APAC Guselkumab Injection Sales Market Share by Region (2018-2023)
Table 41. APAC Guselkumab Injection Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Guselkumab Injection Revenue Market Share by Region (2018-2023)
Table 43. APAC Guselkumab Injection Sales by Type (2018-2023) & (K Units)
Table 44. APAC Guselkumab Injection Sales by Application (2018-2023) & (K Units)
Table 45. Europe Guselkumab Injection Sales by Country (2018-2023) & (K Units)
Table 46. Europe Guselkumab Injection Sales Market Share by Country (2018-2023)
Table 47. Europe Guselkumab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Guselkumab Injection Revenue Market Share by Country (2018-2023)
Table 49. Europe Guselkumab Injection Sales by Type (2018-2023) & (K Units)
Table 50. Europe Guselkumab Injection Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Guselkumab Injection Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Guselkumab Injection Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Guselkumab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Guselkumab Injection Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Guselkumab Injection Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Guselkumab Injection Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Guselkumab Injection
Table 58. Key Market Challenges & Risks of Guselkumab Injection
Table 59. Key Industry Trends of Guselkumab Injection
Table 60. Guselkumab Injection Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Guselkumab Injection Distributors List
Table 63. Guselkumab Injection Customer List
Table 64. Global Guselkumab Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Guselkumab Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Guselkumab Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Guselkumab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Guselkumab Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Guselkumab Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Guselkumab Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Guselkumab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Guselkumab Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Guselkumab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Guselkumab Injection Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Guselkumab Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Guselkumab Injection Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Guselkumab Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Janssen Biotech Basic Information, Guselkumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Janssen Biotech Guselkumab Injection Product Portfolios and Specifications
Table 80. Janssen Biotech Guselkumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Janssen Biotech Main Business
Table 82. Janssen Biotech Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Guselkumab Injection
Figure 2. Guselkumab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Guselkumab Injection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Guselkumab Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Guselkumab Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 100mg Type
Figure 10. Product Picture of Other
Figure 11. Global Guselkumab Injection Sales Market Share by Type in 2022
Figure 12. Global Guselkumab Injection Revenue Market Share by Type (2018-2023)
Figure 13. Guselkumab Injection Consumed in Plaque Psoriasis
Figure 14. Global Guselkumab Injection Market: Plaque Psoriasis (2018-2023) & (K Units)
Figure 15. Guselkumab Injection Consumed in Other
Figure 16. Global Guselkumab Injection Market: Other (2018-2023) & (K Units)
Figure 17. Global Guselkumab Injection Sales Market Share by Application (2022)
Figure 18. Global Guselkumab Injection Revenue Market Share by Application in 2022
Figure 19. Guselkumab Injection Sales Market by Company in 2022 (K Units)
Figure 20. Global Guselkumab Injection Sales Market Share by Company in 2022
Figure 21. Guselkumab Injection Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Guselkumab Injection Revenue Market Share by Company in 2022
Figure 23. Global Guselkumab Injection Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Guselkumab Injection Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Guselkumab Injection Sales 2018-2023 (K Units)
Figure 26. Americas Guselkumab Injection Revenue 2018-2023 ($ Millions)
Figure 27. APAC Guselkumab Injection Sales 2018-2023 (K Units)
Figure 28. APAC Guselkumab Injection Revenue 2018-2023 ($ Millions)
Figure 29. Europe Guselkumab Injection Sales 2018-2023 (K Units)
Figure 30. Europe Guselkumab Injection Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Guselkumab Injection Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Guselkumab Injection Revenue 2018-2023 ($ Millions)
Figure 33. Americas Guselkumab Injection Sales Market Share by Country in 2022
Figure 34. Americas Guselkumab Injection Revenue Market Share by Country in 2022
Figure 35. Americas Guselkumab Injection Sales Market Share by Type (2018-2023)
Figure 36. Americas Guselkumab Injection Sales Market Share by Application (2018-2023)
Figure 37. United States Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Guselkumab Injection Sales Market Share by Region in 2022
Figure 42. APAC Guselkumab Injection Revenue Market Share by Regions in 2022
Figure 43. APAC Guselkumab Injection Sales Market Share by Type (2018-2023)
Figure 44. APAC Guselkumab Injection Sales Market Share by Application (2018-2023)
Figure 45. China Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Guselkumab Injection Sales Market Share by Country in 2022
Figure 53. Europe Guselkumab Injection Revenue Market Share by Country in 2022
Figure 54. Europe Guselkumab Injection Sales Market Share by Type (2018-2023)
Figure 55. Europe Guselkumab Injection Sales Market Share by Application (2018-2023)
Figure 56. Germany Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Guselkumab Injection Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Guselkumab Injection Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Guselkumab Injection Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Guselkumab Injection Sales Market Share by Application (2018-2023)
Figure 65. Egypt Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Guselkumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Guselkumab Injection in 2022
Figure 71. Manufacturing Process Analysis of Guselkumab Injection
Figure 72. Industry Chain Structure of Guselkumab Injection
Figure 73. Channels of Distribution
Figure 74. Global Guselkumab Injection Sales Market Forecast by Region (2024-2029)
Figure 75. Global Guselkumab Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Guselkumab Injection Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Guselkumab Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Guselkumab Injection Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Guselkumab Injection Revenue Market Share Forecast by Application (2024-2029)